These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 186621)

  • 21. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
    Takada K; Osato T
    Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Tonsil B Cell Phenotypes and EBV Receptor Expression in Children Under 5-Years-Old.
    Wohlford EM; Baresel PC; Wilmore JR; Mortelliti AJ; Coleman CB; Rochford R
    Cytometry B Clin Cytom; 2018 Mar; 94(2):291-301. PubMed ID: 28885784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    Stein LD; Ledgley CJ; Sigal NH
    J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation.
    Pope JH; Moss DJ
    IARC Sci Publ (1971); 1978; (24 Pt 2):617-22. PubMed ID: 221385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evidence for the persistence of Epstein-Barr-virus in the parotid gland (author's transl)].
    Wilmes E; Wolf H
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):7-10. PubMed ID: 6261052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
    Aman P; Gordon J; Lewin N; Nordström M; Ehlin-Henriksson B; Klein G; Carstensson A
    J Immunol; 1985 Oct; 135(4):2362-7. PubMed ID: 2993411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis].
    Sauerbrei A; Färber I; Wutzler P; Swoboda R; Schneider J
    Laryngorhinootologie; 1990 Feb; 69(2):70-3. PubMed ID: 2157451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequencies of specific antibody-producing cells for sheep red blood cells and for phosphorylcholine in human tonsillar B lymphocytes transformed by Epstein-Barr virus.
    Yoshie O; Ono Y
    Tohoku J Exp Med; 1982 Jul; 137(3):233-44. PubMed ID: 6287669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells.
    Mordasini V; Ueda S; Aslandogmus R; Berger C; Gysin C; Hühn D; Sartori AA; Bernasconi M; Nadal D
    Oncotarget; 2017 Jan; 8(4):6461-6474. PubMed ID: 28031537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.
    Meru N; Davison S; Whitehead L; Jung A; Mutimer D; Rooney N; Kelly D; Niedobitek G
    Mol Pathol; 2001 Aug; 54(4):264-9. PubMed ID: 11477143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of infectious Epstein--Barr virus in mouse lymphocytes.
    Volsky DJ; Klein G; Volsky B; Shapiro IM
    Nature; 1981 Oct; 293(5831):399-401. PubMed ID: 6268991
    [No Abstract]   [Full Text] [Related]  

  • 37. Serological detection of Epstein-Barr virus infection in dogs and cats.
    Milman G; Smith KC; Erles K
    Vet Microbiol; 2011 May; 150(1-2):15-20. PubMed ID: 21242039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells.
    Leibold W; Flanagan TD; Menezes J; Klein G
    J Natl Cancer Inst; 1975 Jan; 54(1):65-8. PubMed ID: 163326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.